National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
recombinant vaccinia-CEA-MUC-1-TRICOM vaccine (ree-KOM-bih-nunt vak-SIN-ee-uh … vak-SEEN)

 A cancer vaccine made with a form of vaccinia virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins, including the tumor markers called CEA and MUC-1, that may help immune cells in the body kill tumor cells. Also called inalimarev and PANVAC-V.

Previous Definitions:recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine, recombinant human interleukin-2, recombinant human interleukin-11, recombinant tissue plasminogen activator
Next Definitions:recombinant vaccinia-TRICOM vaccine, reconstructive surgeon, reconstructive surgery, recover, recreational therapy